The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports.
about
The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
The risk of bleeding with dulo ...... rketing adverse event reports.
@en
The risk of bleeding with dulo ...... roidal anti-inflammatory drugs
@nl
type
label
The risk of bleeding with dulo ...... rketing adverse event reports.
@en
The risk of bleeding with dulo ...... roidal anti-inflammatory drugs
@nl
prefLabel
The risk of bleeding with dulo ...... rketing adverse event reports.
@en
The risk of bleeding with dulo ...... roidal anti-inflammatory drugs
@nl
P2093
P2860
P356
P1476
The risk of bleeding with dulo ...... arketing adverse event reports
@en
P2093
David G Perahia
Elijah P Frakes
James M Martinez
Mark E Bangs
Michael J Adams
Yingkai Cheng
P2860
P304
P356
10.2147/DHPS.S45445
P407
P50
P577
2013-11-25T00:00:00Z